Acute-phase response in patients given rhIL-3 after chemotherapy
- 27 June 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 339 (8809) , 1616-1617
- https://doi.org/10.1016/0140-6736(92)91887-e
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Recombinant human granulocyte-macrophage colony-stimulating factor accelerates neutrophil and monocyte recovery after allogeneic T-cell- depleted bone marrow transplantationBlood, 1992
- Interactions of granulocyte-macrophage colony-stimulating factor (CSF), granulocyte CSF, and tumor necrosis factor alpha in the priming of the neutrophil respiratory burstBlood, 1992
- Human recombinant GM-CSF in allogeneic bone-marrow transplantation for leukaemia: double-blind, placebo-controlled trialThe Lancet, 1990
- From the Infectious Diseases Society of America: Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained FeverThe Journal of Infectious Diseases, 1990
- Functional discrimination between interleukin 6 and interleukin 1European Journal of Immunology, 1988